Hub genes and their key effects on prognosis of Burkitt lymphoma

doi:10.5306/wjco.v14.i10.357

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3187)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1135

Figures (1-9)

287

Tables (1-1)

225

Sum=1727

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

242

Download

574

Sum=816

Publishing Process of This Article

Item

Count

Browse

112

Download

456

Sum=568

Oct 24, 2023 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Oct 24, 2023; 14(10): 357-372
Published online Oct 24, 2023. doi: 10.5306/wjco.v14.i10.357

Full Size Figure Download Figure

Figure 9 Drugs related to IL2RA and CXCL10.

Citation: Xu YF, Wang GY, Zhang MY, Yang JG. Hub genes and their key effects on prognosis of Burkitt lymphoma. World J Clin Oncol 2023; 14(10): 357-372
URL: https://www.wjgnet.com/2218-4333/full/v14/i10/357.htm
DOI: https://dx.doi.org/10.5306/wjco.v14.i10.357